|
| 35263656 | Tobacco Product Use and Functionally Important Respiratory Symptoms Among US Adolescents/Young Adults. | Acad Pediatr | 2022 |
| 35366322 | Tobacco Use and Respiratory Symptoms Among Adults: Findings From the Longitudinal Population Assessment of Tobacco and Health (PATH) Study 2014-2016. | Nicotine Tob Res | 2022 |
| 37483395 | Case Report: It's a Small Whirl Afterall. | | 2022 |
| 34574610 | Validation of an Index for Functionally Important Respiratory Symptoms among Adults in the Nationally Representative Population Assessment of Tobacco and Health Study, 2014-2016. | Int J Environ Res Public Health | 2021 |
| 34259831 | Posttraumatic Stress Disorder and Cardiovascular Disease: State of the Science, Knowledge Gaps, and Research Opportunities. | JAMA Cardiol | 2021 |
| 33419908 | Disclosure of study funding and author conflicts of interest in press releases and the news: a retrospective content analysis with two cohorts. | BMJ Open | 2021 |
| 31985742 | A National Survey of the Frequency of Drug Company Detailing Visits and Free Sample Closets in Practices Delivering Primary Care. | JAMA Internal Medicine | 2020 |
| 30667474 | Physicians' Perspectives on FDA Approval Standards and Off-label Drug Marketing. | JAMA Intern Med | 2019 |
| 31707825 | Randomized Study of Providing Evidence Context to Mitigate Physician Misinterpretation Arising From Off-Label Drug Promotion. | Circ Cardiovasc Qual Outcomes | 2019 |
| 30592484 | Trends in Testosterone Prescribing for Age-related Hypogonadism in Men With and Without Heart Disease. | JAMA Internal Medicine | 2019 |
| 30543020 | Timeliness of Postmarket Studies for New Pharmaceuticals Approved Between 2009 and 2012: a Cross-Sectional Analysis. | J Gen Intern Med | 2019 |
| 30291605 | Internal Medicine Physicians' Financial Relationships with Industry: An Updated National Estimate. | J Gen Intern Med | 2019 |
| 30632890 | Visual Representations of Risk Enhance Long-Term Retention of Risk Information: A Randomized Trial. | Medical Decision Making | 2019 |
| 30620375 | Medical Marketing in the United States, 1997-2016. | JAMA - Journal of the American Medical Association | 2019 |
| 29789307 | Overcoming overuse: the way forward is not standing still-an essay by Steven Woloshin and Lisa M Schwartz. | BMJ, The | 2018 |
| 30120097 | Focusing on overdiagnosis as a driver of too much medicine. | BMJ, The | 2018 |
| 30066118 | How Do Women View Risk-Based Mammography Screening? A Qualitative Study. | J Gen Intern Med | 2018 |
| 30012703 | Deciphering the Role of Lipid Droplets in Cardiovascular Disease: A Report From the 2017 National Heart, Lung, and Blood Institute Workshop. | Circulation | 2018 |
| 29351451 | Guidelines for experimental models of myocardial ischemia and infarction. | Am J Physiol Heart Circ Physiol | 2018 |
| 29297040 | A Clear-eyed View of Restasis and Chronic Dry Eye Disease. | JAMA Internal Medicine | 2018 |
| 29596008 | Psychotropic medications for highly vulnerable children. | Expert Opinion on Pharmacotherapy | 2018 |
| 29367314 | Overdiagnosis: what it is and what it isn't. | BMJ Evidence-Based Medicine | 2018 |
| 29362786 | Characteristics of Interim Publications of Randomized Clinical Trials and Comparison With Final Publications. | JAMA - Journal of the American Medical Association | 2018 |
| 29794072 | Postmarket studies required by the US Food and Drug Administration for new drugs and biologics approved between 2009 and 2012: cross sectional analysis. | BMJ | 2018 |
| 28278389 | Clinical Equipoise and Shared Decision-making in Pulmonary Nodule Management. A Survey of American Thoracic Society Clinicians. | Ann Am Thorac Soc | 2017 |
| 28341221 | A Systematic Review of Obesity Disparities Research. | American Journal of Preventive Medicine | 2017 |
| 28339323 | Media Coverage of FDA Drug Safety Communications about Zolpidem: A Quantitative and Qualitative Analysis. | J Health Commun | 2017 |
| 28930510 | The Fate of FDA Postapproval Studies. | New England Journal of Medicine | 2017 |
| 28738058 | Establishing a library of resources to help people understand key concepts in assessing treatment claims-The "Critical thinking and Appraisal Resource Library" (CARL). | PLoS ONE | 2017 |
| 29236629 | The Fate of FDA Postapproval Studies. | New England Journal of Medicine | 2017 |
| 27918816 | Cancer Care Institutions and Advertising-Reply. | JAMA Internal Medicine | 2016 |
| 27294570 | ClinicalTrials.gov and Drugs@FDA: A Comparison of Results Reporting for New Drug Approval Trials. | Annals of Internal Medicine | 2016 |
| 26926770 | US Food and Drug Administration Approval of Flibanserin: Even the Score Does Not Add Up. | JAMA Internal Medicine | 2016 |
| 26742098 | Prefrontal glutamate correlates of methamphetamine sensitization and preference. | Eur J Neurosci | 2016 |
| 26961390 | Patients' Knowledge, Beliefs, and Distress Associated with Detection and Evaluation of Incidental Pulmonary Nodules for Cancer: Results from a Multicenter Survey. | J Thorac Oncol | 2016 |
| 27399794 | Cancer Center Advertising-Where Hope Meets Hype. | JAMA Internal Medicine | 2016 |
| 27115269 | Physicians' Knowledge About FDA Approval Standards and Perceptions of the "Breakthrough Therapy" Designation. | JAMA | 2016 |
| 27598752 | Appropriate Perspective and Context for Newly Approved Medications, Including Flibanserin-Reply. | JAMA Internal Medicine | 2016 |
| 23252477 | 'The thing is not knowing': patients' perspectives on surveillance of an indeterminate pulmonary nodule. | Health Expect | 2015 |
| 25679109 | Attitudes about low-dose computed tomography screening for lung cancer: a survey of American Thoracic Society Clinicians. | Am J Respir Crit Care Med | 2015 |
| 25968811 | Methodological approaches to evaluate the impact of FDA drug safety communications. | Drug Saf | 2015 |
| 26185209 | Harnessing the Power of Integrated Mitochondrial Biology and Physiology: A Special Report on the NHLBI Mitochondria in Heart Diseases Initiative. | Circ Res | 2015 |
| 26390245 | A Randomized Trial Testing US Food and Drug Administration "Breakthrough" Language. | JAMA Internal Medicine | 2015 |
| 26201399 | Erratum to: Methodological Approaches to Evaluate the Impact of FDA Drug Safety Communications. | Drug Saf | 2015 |
| 25090180 | Drug treatment of obesity--reply. | JAMA Internal Medicine | 2014 |
| 25417239 | Providing clinicians and patients with actual prognosis: cancer in the context of competing causes of death. | Journal of the National Cancer Institute. Monographs | 2014 |
| 25417232 | When do changes in cancer survival mean progress? The insight from population incidence and mortality. | Journal of the National Cancer Institute. Monographs | 2014 |
| 25417231 | Cancer survival: an overview of measures, uses, and interpretation. | Journal of the National Cancer Institute. Monographs | 2014 |
| 25423223 | US Food and Drug Administration and design of drug approval studies. | JAMA - Journal of the American Medical Association | 2014 |
| 24354970 | Using radiology reports to encourage evidence-based practice in the evaluation of small, incidentally detected pulmonary nodules. A preliminary study. | Annals of the American Thoracic Society | 2014 |